Fang Q, Liu X, Abe S, Kobayashi T, Wang X Q, Kohyama T, Hashimoto M, Wyatt T, Rennard S I
University of Nebraska Medical Center, 985125 Nebraska Medical Center, Omaha, NE, USA.
Eur Respir J. 2004 Dec;24(6):918-24. doi: 10.1183/09031936.04.00005704.
The ability of fibroblasts to contract three-dimensional collagen gels has been used as an in vitro model of the tissue contraction which characterises both normal repair and fibrosis. Among its actions, thrombin can activate the protease-activated receptor (PAR)1 and, thereby, stimulate inflammation and repair. The current study evaluated whether thrombin could stimulate fibroblast-mediated collagen gel contraction by activating PAR1 and whether its downstream signalling depends on protein kinase C (PKC)-epsilon. Human foetal lung fibroblasts (HFL-1) were cultured in three-dimensional collagen gels and the area of the gels was measured by image analyser. Both thrombin and TFLLR, a selective PAR1 agonist, stimulated collagen gel contraction mediated by HFL-1. After RNA interference-mediated PAR1 knockdown in HFL-1, both thrombin and the PAR1 agonist-induced gel contraction were partially inhibited (by 22.4+/-2.2% and 17.6+/-5.6%, respectively). The gel contraction stimulated by thrombin was also reduced by a nonspecific PKC inhibitor and a calcium-independent PKC-epsilon inhibitor. Both thrombin and TFLLR significantly increased PKC-epsilon activity, and this effect was blocked by PAR1 knockdown. Thrombin stimulates collagen gel contraction at least partially through activation of protease-activated receptor 1 and protein kinase C-epsilon, and may contribute to tissue remodelling in inflammatory airway and lung diseases.
成纤维细胞收缩三维胶原凝胶的能力已被用作组织收缩的体外模型,该模型可表征正常修复和纤维化过程。在其作用中,凝血酶可激活蛋白酶激活受体(PAR)1,从而刺激炎症和修复。本研究评估了凝血酶是否可通过激活PAR1刺激成纤维细胞介导的胶原凝胶收缩,以及其下游信号传导是否依赖于蛋白激酶C(PKC)-ε。将人胎儿肺成纤维细胞(HFL-1)培养于三维胶原凝胶中,并用图像分析仪测量凝胶面积。凝血酶和选择性PAR1激动剂TFLLR均刺激了HFL-1介导的胶原凝胶收缩。在HFL-1中通过RNA干扰介导PAR1基因敲低后,凝血酶和PAR1激动剂诱导的凝胶收缩均受到部分抑制(分别为22.4±2.2%和17.6±5.6%)。非特异性PKC抑制剂和钙非依赖性PKC-ε抑制剂也降低了凝血酶刺激的凝胶收缩。凝血酶和TFLLR均显著增加了PKC-ε活性,且这种作用被PAR1基因敲低所阻断。凝血酶至少部分通过激活蛋白酶激活受体1和蛋白激酶C-ε刺激胶原凝胶收缩,并可能在炎症性气道和肺部疾病的组织重塑中发挥作用。